{"nct_id":"NCT02201303","title":"Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2014-01-13","start_date_type":"ACTUAL","primary_completion_date":"2015-07-02","primary_completion_date_type":"ACTUAL","completion_date":"2015-07-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}